‘Inhaled’ version of COVID vaccine set to enter second phase of human trials in Canada

(LifeSiteNews) – A new experimental “adenoviral-vectored” trial COVID vaccine that can be inhaled rather than injected and was in part developed with abortion-tainted cell lines will soon enter phase two of human trials in Canada.

The inhaled trial version of the COVID “trivalent adenoviral-vectored” vaccine is made in Canada and developed at McMaster University in Hamilton, Ontario. The new vaccine was created with funding from the Canadian federal government.

Read the entire article …

This entry was posted in Uncategorized. Bookmark the permalink.